Photosynthetic productivity parameters were determined for mayweed chamomile, a troublesome annual weed of the cropping systems in the Pacific Northwest. At a photosynthetic photon flux density of 1800 μE m−2 s–1, maximum net photosynthetic rate of greenhouse-grown plants was 35 mg CO2 dm−2 h–1 and maximum transpiration rate was 6.7 μg H2O cm−2 s–1. Dark respiration rate was 1.4 mg CO2 dm−2 h–1 and the light compensation point was 17.5 μE m−2 s–1. Carbon dioxide compensation point increased from 25 ppm at 15 C to 43 ppm at 30 C. At saturating photosynthetic photon flux densities, optimum leaf temperature for net photosynthesis was about 25 C. Maximum net photosynthesis of leaves of field-grown plants averaged 15.8 mg CO2 dm−2 h–1. After a 24-h exposure to 0.075 kg ha–1 metribuzin, maximum net photosynthesis and transpiration were reduced 85 and 40%, respectively. Soil water deficits reduced maximum net photosynthesis about 50%.

Mayweed chamomile seeds were collected from six different fields across the Pacific Northwest. All populations (each collection site was considered a population) were suspected to have some level of acetolactate synthase (ALS) resistance. Greenhouse and laboratory studies were conducted to determine if these populations were resistant to three different classes of ALS inhibitors: sulfonylureas (SU), imidazolinones (IMI), and triazolopyrimidines (TP). A whole-plant dose–response and in vitro ALS activity studies confirmed cross-resistance to thifensulfuron + tribenuron/chlorsulfuron (SU), imazethapyr (IMI), and cloransulam (TP); however, resistance varied by herbicide class and population. Two ALS isoforms of the ALS gene (ALS1 and ALS2) were identified in mayweed chamomile; however, only mutations in ALS1 were responsible for resistance. No mutations were found in ALS2. Sequence analysis of the partial ALS gene identified four point mutations at position 197 (Pro197 to Leu, Gln, Thr, or Ser) in the resistant populations. This study demonstrates genotypic variation associated with cross-resistance to ALS inhibitors within and between populations.